mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.
Int J Cancer
; 138(10): 2312-21, 2016 May 15.
Article
in En
| MEDLINE
| ID: mdl-26452336
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lung Diseases, Interstitial
/
Protein Kinase Inhibitors
/
TOR Serine-Threonine Kinases
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Int J Cancer
Year:
2016
Type:
Article
Affiliation country:
Netherlands